GGrantIndex
← Leaderboards

Patricia Veronica Aguilar

Icahn School Of Medicine At Mount Sinai

$2,319,917
Attributed
$3,775,806
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $600.3K · FY201325
$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,775,806 · 5

By mechanism

D43$2,152,085 · 1
R21$1,324,341 · 3
R41$299,380 · 1

Top collaborators

Most similar at Icahn School Of Medicine At Mount Sinai

Same institution · by research overlap

Others in their field

Top investigators on “Fever

Research focus

FeverPathogenPublic HealthCountryLatin AmericaMortalityInfectionAcuteDiagnosisDengueMorbidity - Disease RateVirusInfectious Diseases ResearchInstitutionEnrollmentDoctoral StudentIncidenceMethodologyGrantHealth ProfessionalAwarenessHealth PersonnelColombiaAuthority

Grant awards (15)

Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses$297,374
D43 · FY2025 · TW · contact PI
Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses$297,388
D43 · FY2024 · TW · contact PI
Evolution of Mayaro virus and its impact on transmission by urban vectors$200,000
R21 · FY2024 · AI · contact PI
Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses$297,402
D43 · FY2023 · TW · contact PI
Evolution of Mayaro virus and its impact on transmission by urban vectors$240,000
R21 · FY2023 · AI · contact PI
Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses$296,935
D43 · FY2022 · TW · contact PI
Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses$300,959
D43 · FY2021 · TW · contact PI
Thermostable Inactivated Potent Yellow Fever Vaccine$299,380
R41 · FY2021 · AI
Research Training Program on the Impact of Zoonotic and Vector-borne Viruses, Rickettsiae, and Leptospira in Acute Undifferentiated Febrile Illnesses$217,091
D43 · FY2020 · TW · contact PI
Research Training Program on the Impact of Zoonotic and Vector-borne Viruses, Rickettsiae, and Leptospira in Acute Undifferentiated Febrile Illnesses$224,372
D43 · FY2019 · TW · contact PI
Research Training Program on the Impact of Zoonotic and Vector-borne Viruses, Rickettsiae, and Leptospira in Acute Undifferentiated Febrile Illnesses$220,564
D43 · FY2018 · TW · contact PI
Hijacking of cellular pathways by novel tick-borne phlebovirus$192,628
R21 · FY2016 · AI · contact PI
Hijacking of cellular pathways by novel tick-borne phlebovirus$231,400
R21 · FY2015 · AI · contact PI
Naturally occurring human antibodies to alphavirus infection$199,239
R21 · FY2014 · AI
Naturally occurring human antibodies to alphavirus infection$261,074
R21 · FY2013 · AI